Weiss Multi-Strategy Advisers’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-904
Closed -$839K 744
2020
Q4
$839K Sell
904
-1,496
-62% -$1.57M 0.02% 507
2020
Q3
$2.47M Sell
2,400
-524
-18% -$564K 0.07% 316
2020
Q2
$2.96M Buy
2,924
+131
+5% +$122K 0.08% 285
2020
Q1
$2.43M Sell
2,793
-107
-4% -$106K 0.09% 233
2019
Q4
$3.11M Buy
+2,900
New +$2.96M 0.05% 376
2019
Q3
Sell
-260
Closed -$294K 625
2019
Q2
$294K Sell
260
-1,140
-81% -$1.25M 0.01% 453
2019
Q1
$1.9M Buy
1,400
+600
+75% +$814K 0.05% 337
2018
Q4
$926K Sell
800
-2,216
-73% -$2.49M 0.04% 306
2018
Q3
$4.58M Buy
3,016
+16
+0.5% +$24.6K 0.12% 214
2018
Q2
$4.7M Sell
3,000
-720
-19% -$939K 0.11% 230
2018
Q1
$4.3M Sell
3,720
-80
-2% -$105K 0.14% 195
2017
Q4
$4.5M Sell
3,800
-1,000
-21% -$1.25M 0.12% 202
2017
Q3
$6.46M Buy
+4,800
New +$5.06M 0.24% 116

Other funds holding KYNB

Weiss Multi-Strategy Advisers's KYNB Position: Q1 2021 in Review

Weiss Multi-Strategy Advisers sold out of Kyntra Bio (KYNB) in Q1 2021, closing a stake of 904 shares — an estimated $839K sold.

Weiss Multi-Strategy Advisers first reported a position in KYNB in Q3 2017 and held it in 13 quarters. The position peaked at $6.46M in Q3 2017. 198 funds tracked by Wall St. Rank hold KYNB as of Q1 2021.

  • Weiss Multi-Strategy Advisers reported no remaining Kyntra Bio position as of Q1 2021 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 904 Kyntra Bio shares in Q1 2021, an estimated $839K.
  • Weiss Multi-Strategy Advisers first reported a position in Kyntra Bio in Q3 2017 and held it in 13 quarters.
  • Weiss Multi-Strategy Advisers's Kyntra Bio position peaked at $6.46M in Q3 2017.
  • 198 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2021.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2021, filed 14 May 2021.